Idexx Laboratories (IDXX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 1,105,239 | 1,109,457 | 998,427 | 954,288 | 975,543 |
| Cost of Goods | 421,885 | 414,725 | 375,048 | 383,628 | 379,505 |
| Gross Profit | 683,354 | 694,732 | 623,379 | 570,660 | 596,038 |
| Operating Expenses | 329,393 | 322,411 | 306,893 | 309,602 | 292,651 |
| Operating Income | 354,846 | 373,046 | 316,534 | 261,686 | 303,892 |
| Interest Expense | 10,655 | 11,321 | 7,666 | 7,498 | 7,697 |
| Other Income | 580 | 627 | 1,216 | 2,199 | 2,714 |
| Pre-tax Income | 344,771 | 362,352 | 310,084 | 256,387 | 298,909 |
| Income Tax | 70,161 | 68,363 | 67,407 | 40,238 | 66,068 |
| Net Income Continuous | 274,610 | 293,989 | 242,677 | 216,149 | 232,841 |
| Net Income | $274,610 | $293,989 | $242,677 | $216,149 | $232,841 |
| EPS Basic Total Ops | 3.43 | 3.66 | 2.98 | 2.64 | 2.83 |
| EPS Basic Continuous Ops | 3.43 | 3.66 | 2.98 | 2.64 | 2.83 |
| EPS Diluted Total Ops | 3.40 | 3.63 | 2.96 | 2.62 | 2.80 |
| EPS Diluted Continuous Ops | 3.40 | 3.63 | 2.96 | 2.62 | 2.80 |
| EPS Diluted Before Non-Recurring Items | 3.40 | 3.63 | 2.96 | 2.62 | 2.80 |
| EBITDA(a) | $391,473 | $408,818 | $350,597 | $295,392 | $338,025 |